Clorox (CLX) is drawing renewed attention after recent trading left the stock at a last close of $95.55. This has prompted investors to reassess how its household and wellness portfolio lines up with current valuation metrics.

Recent moves put Clorox’s latest 1 day share price return of 1.87% against a year to date share price return that is down 5.26%, while the 1 year total shareholder return has declined 21.52%. This suggests sentiment has been weak and momentum subdued despite the recent uptick.

If you are weighing Clorox against other opportunities in consumer facing businesses, it can help to broaden your search and check out 18 top founder-led companies

After a long stretch of weak total returns, Clorox has inched higher off recent lows. This raises a more basic question: is most of the recovery potential already gone, or is the bulk of the upside still ahead as you look at valuation next?

Most Popular Narrative: 9.3% Undervalued

Compared with Clorox's last close at $95.55, the most followed narrative points to a fair value of $105.29, using a 7.11% discount rate and detailed long term cash flow assumptions.

The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs, which should support margin expansion and sustained earnings growth once short-term transition noise normalizes.

The fair value hinges on how consistently Clorox converts these efficiency gains into future earnings. Revenue growth, stable margins, and a tighter share count sit at the core. Curious which combination of those inputs needs to hold for the $105.29 figure to stack up, and how that compares to where the stock trades today.

Result: Fair Value of $105.29 (UNDERVALUED)

However, the Clorox narrative can still be knocked off course if sluggish category growth lingers or if price competition in areas like Glad and cat litter keeps pressuring margins.

Next Steps

With sentiment on Clorox clearly mixed, weigh the concerns and the potential before the story moves on. Use the 4 key rewards and 2 important warning signs to test your own view.

Looking for more investment ideas beyond Clorox?

If Clorox has sharpened your focus on quality, do not stop here. Broaden your watchlist with a few targeted stock ideas that match different investing styles.

• Target stronger value opportunities by scanning companies that look mispriced on fundamentals using the 50 high quality undervalued stocks.
• Prioritize resilience by checking businesses with robust finances and healthier leverage profiles via the solid balance sheet and fundamentals stocks screener (49 results).
• Spot early stage opportunities with quality traits that the market may be overlooking through the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.